Cassowary Capital announces that, further to the Corporation's news release dated November 22, 2018, it has terminated the non-binding letter of intent with Lobo Genetics Inc. and will no longer be proceeding with the proposed reverse takeover of Cassowary by Lobo. The transaction was intended to constitute Cassowary's Qualifying Transaction. No deposit or cash advance was made by Cassowary to Lobo in connection with the [...]
Cassowary Capital is pleased to announce that it has entered into a non-binding letter of intent with Lobo Genetics Inc., and together with BIRD dated November 20, 2018, pursuant to which the Parties will complete a transaction that will result in a reverse takeover of BIRD by Lobo. BIRD is a Capital Pool Company as defined in the policies of the TSXV, and intends for the Acquisition to constitute its Qualifying [...]
Cassowary Capital is pleased to announce that on September 6, 2018, it has successfully completed its initial public offering, raising gross proceeds of $400,000 pursuant to a prospectus dated July 30, 2018. An aggregate of 4,000,000 common shares in the capital of the Corporation were subscribed for at a price of $0.10 per Share. The Corporation has received conditional listing approval from the TSX Venture Exchange for [...]
+700,00 %
-95,12 %
